Steglujan

Steglujan Indications/Uses

ertugliflozin + sitagliptin

Manufacturer:

MSD

Distributor:

Zuellig
Full Prescribing Info
Indications/Uses
Steglujan is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control: when metformin and/or a sulphonylurea (SU) and one of the monocomponents of Steglujan do not provide adequate glycaemic control; in patients already being treated with the combination of ertugliflozin and sitagliptin as separate tablets.
(For study results with respect to combinations and effects on glycaemic control, see Precautions, Interactions, and Pharmacology: Pharmacodynamics under Actions.)
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in